CN103319414A - Improved telmisartan preparation process - Google Patents
Improved telmisartan preparation process Download PDFInfo
- Publication number
- CN103319414A CN103319414A CN 201310270872 CN201310270872A CN103319414A CN 103319414 A CN103319414 A CN 103319414A CN 201310270872 CN201310270872 CN 201310270872 CN 201310270872 A CN201310270872 A CN 201310270872A CN 103319414 A CN103319414 A CN 103319414A
- Authority
- CN
- China
- Prior art keywords
- reaction
- methyl
- product
- acid
- cyclization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RMMXLENWKUUMAY-UHFFFAOYSA-N Telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 title claims abstract description 17
- 239000005537 C09CA07 - Telmisartan Substances 0.000 title claims abstract description 16
- 229960005187 telmisartan Drugs 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title description 13
- 239000000047 product Substances 0.000 claims abstract description 18
- 239000012043 crude product Substances 0.000 claims abstract description 13
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 13
- 238000006396 nitration reaction Methods 0.000 claims abstract description 10
- 238000006722 reduction reaction Methods 0.000 claims abstract description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 9
- 238000000746 purification Methods 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000012295 chemical reaction liquid Substances 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 34
- 239000007787 solid Substances 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 15
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 229960000583 Acetic Acid Drugs 0.000 claims description 7
- 150000001408 amides Chemical class 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000012362 glacial acetic acid Substances 0.000 claims description 6
- 229940095102 methyl benzoate Drugs 0.000 claims description 6
- 239000012065 filter cake Substances 0.000 claims description 5
- PNPIRSNMYIHTPS-UHFFFAOYSA-N nitroso nitrate Chemical compound [O-][N+](=O)ON=O PNPIRSNMYIHTPS-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000001143 conditioned Effects 0.000 claims description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 claims description 2
- 230000000802 nitrating Effects 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims 3
- 239000003513 alkali Substances 0.000 claims 1
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000006011 modification reaction Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 238000001953 recrystallisation Methods 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 5
- 230000001105 regulatory Effects 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- XWAJTVCEILFDGU-UHFFFAOYSA-N 7-methyl-2-propyl-3H-benzimidazole-5-carboxylic acid Chemical compound C1=C(C(O)=O)C=C2NC(CCC)=NC2=C1C XWAJTVCEILFDGU-UHFFFAOYSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- RZMQQYDXKPDLJH-UHFFFAOYSA-N methyl 4-(butanoylamino)-3-methylbenzoate Chemical compound CCCC(=O)NC1=CC=C(C(=O)OC)C=C1C RZMQQYDXKPDLJH-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 15
- 238000003756 stirring Methods 0.000 description 12
- 238000010992 reflux Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- 239000007789 gas Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000012970 cakes Nutrition 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000003912 environmental pollution Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 229960000935 Dehydrated Alcohol Drugs 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- IEFONJKJLZFGKQ-UHFFFAOYSA-N methyl 3-methyl-4-nitrobenzoate Chemical class COC(=O)C1=CC=C([N+]([O-])=O)C(C)=C1 IEFONJKJLZFGKQ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000001264 neutralization Effects 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing Effects 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- IWRJMQUPCKSBFP-UHFFFAOYSA-N 2-N-methylbenzene-1,2-diamine;hydrochloride Chemical compound Cl.CNC1=CC=CC=C1N IWRJMQUPCKSBFP-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N Butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N N-Butylamine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- QCOGKXLOEWLIDC-UHFFFAOYSA-N N-methylbutylamine Chemical group CCCCNC QCOGKXLOEWLIDC-UHFFFAOYSA-N 0.000 description 1
- AYDQIZKZTQHYIY-UHFFFAOYSA-N OC(=O)C1(C)CC(C(O)=O)=CC=C1 Chemical compound OC(=O)C1(C)CC(C(O)=O)=CC=C1 AYDQIZKZTQHYIY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- -1 filter Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001631 hypertensive Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 230000036454 renin-angiotensin system Effects 0.000 description 1
- 230000000630 rising Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Abstract
The invention provides an improved process for preparing a telmisartan raw material medicament. The improved process comprises the following step: preparing an intermediate 2-n-propyl-4-methyl-benzimidazole-6-carboxylic acid by using methyl 4-butylacetamino-3-methylbenzoate as a raw material through four steps, namely nitration, reduction, cyclization and hydrolysis. According to the process, crude products in nitrification, reduction and cyclization reactions are not subjected to purification and separation, and a target product can be separated by regulating the pH of a reaction liquid obtained in a hydrolysis reaction to be between 6 and 7, so that the problems of complicated operation and yield loss caused by separation of nitrified and reduced products by recrystallization and chromatographic separation of a cyclized product by a column are solved. Therefore, the purity of the prepared telmisartan crude product is over 99 percent after recrystallization. The improved process is simple to operate, high in yield and low in cost, and is advantageous to industrial production.
Description
Technical field
The invention belongs to organic chemistry filed, thereby specifically be the production cost of simplifying the production operation reduction telmisartan of 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid.
Background technology
2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid is a key intermediate of preparation antihypertensive drug telmisartan.And telmisartan can block renin-angiotensin system fully because having the effect of specificity inhibition AT II.Telmisartan is the longest AT II receptor antagonist class medicine of transformation period in addition, so it becomes one of hypertensive medicine for the treatment of commonly used clinically.
Synthesis technique for 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid, have a lot of relevant patents and bibliographical information (as CN101838243A, CN101921235A, CN1412183A, US5591762, CN102267949A, WO200510837, J.Med.chem.1993,36 (25) 4040-4051) both at home and abroad.Bibliographical information 2-n-propyl-4-methyl-benzoglyoxaline-the most frequently used synthetic method of 6-carboxylic acid is to be made through nitrated, reduction, cyclization and hydrolysis by the positive amide-based small methyl benzoate 4 of 3-methyl-4-.Wherein the reaction formula of nitration reaction is as follows:
The nitration reaction products therefrom is outside the master divided by the positive amide-based small of 3-methyl-4--5-nitrobenzoic acid methyl esters 5, and also have following several: (1) nitro is in single nitration product (5a or 5b) of methyl ortho para; (2) all there is many nitrations product (5c) of nitro at methyl and n-Butyl Amine 99 acyl group ortho position.The pure system of nitrated crude product is the difficult problem that nitration reaction will solve.Because main by product 5a, 5b only are the position of functional group isomer of principal product 5, close structure extremely is unfavorable for the pure system of nitrated crude product.Wherein bibliographical information is to the separating of 5a, 5b and 5c, and the method that adopts is recrystallization or column chromatography usually.In addition, compound 5 crude product after reducing also needs recrystallization to purify; And the purification of cyclization product is used especially the column chromatography of complex operation.Adopt the pure system loss of recrystallization method bigger, each recrystallization loss will account for about 10% of product, and a recrystallization is difficult to obtain satisfied pure products; Adopt column chromatography for separation, cost is too high, is unfavorable for suitability for industrialized production.
Therefore, purpose of the present invention is for providing a kind of technology of improved preparation telmisartan, in the process of nitrated, reduction, cyclization, hydrolysis four steps preparation 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid, the separation of not purifying of the crude product of nitrated, reduction and ring-closure reaction, separate out the purpose that target product reaches purification by pH to 6～7 of regulating hydrolysis reaction gained reaction solution, simplify the operation course, improve target product yield, be more suitable in suitability for industrialized production.
Summary of the invention
The objective of the invention is to solve that cost height in the existing telmisartan synthesis technique, environmental pollution are big, complex operation etc. is unfavorable for industrial difficult point problem, a kind of novel process for preparing telmisartan is provided, this technological operation is simple and easy, cost is low, environmental pollution is little, yield is higher, is fit to suitability for industrialized production.
The synthetic route that the present invention adopts is as follows:
The present invention includes the following step:
Compound 4 in-15～-12 ℃, reacted 3～5 hours under the effect of 95% nitrosonitric acid.After elutriation on the rocks went out yellow solid, filtration, filtration cakes torrefaction got compound 5 crude products.The crude product of compound 5 behind the hydrogenation reduction, filters filtering catalysis and adds under Raney Ni catalysis, pressurization steam desolventize compound 6 crude products.The crude product of compound 6 back flow reaction 1 hour under the Glacial acetic acid effect removes Glacial acetic acid under reduced pressure, hydrolysis in the methanol-water system, steam except conditioned reaction liquid pH behind the methyl alcohol be 6～7 get final product compound 7 elaboration.
The present invention has following advantage:
1. simplified control is compared other technology, preparation midbody compound 5,6 and the cyclization product all do not relate to and separate the purification problem, therefore can shorten the production cycle, reduce production costs, improve productive rate.
2. environmental pollution is little, replaces nitric-sulfuric acid as nitrating agent with nitrosonitric acid, reduces the difficulty of wastewater treatment, thereby saves production cost.
Embodiment:
The invention will be further described below in conjunction with embodiment, but and can't help these examples and limit the scope of the invention.
Embodiment 1
The preparation of 3-methyl-4-nitrobenzoic acid methyl esters (2)
In the 3L there-necked flask that reflux condensing tube and thermometer are housed of drying, add 300g3-methyl-4-nitrobenzoic acid 1(1.66mol) and 1000mL methyl alcohol, on reflux condensing tube, make a simple and easy device for absorbing tail gas, absorption liquid is the NaOH aqueous solution.Dropwise add 100g thionyl chloride (0.85mol) with constant pressure funnel under the induction stirring, the temperature of reaction solution is between 30-40 ℃ in the control dropping process, and this moment, reaction solution was milky white solution.About 45min dropwises, heat temperature raising to 60 ℃, and this moment, reactant was yellow clear solution.Stirring and refluxing reaction 2h stops heating under this temperature, and reaction solution slowly cools off, and separates out a large amount of solids during to 50 ℃.Continue cooling and be down to 30 ℃, 1000mL water is added in the reaction solution, stir about is emitted to no longer including gas half an hour, filtering reaction thing, gained filter cake be with 100mL * 3 water washings, in 40 ℃ dry 314g yellow powder shape solid, productive rate 97.2%, m.p.80～82 ℃.
Embodiment 2
The preparation of 3-methyl-4-Methyl anthranilate (3)
In 2L hydrogenation still, add the 1.2mL dehydrated alcohol, 6.5g Raney Ni catalyzer and 130g compound 2 pump air with oil pump, logical N
2Gas is drained air in the still for three times, leads to H in still
2Gas is to 1.2MPa.Adjust the reactor controller, be warming up to 80 ℃ after observing response still internal pressure, when hydrogen pressure no longer reduces, react 2h with this understanding.Reactant is cooled to room temperature, discharges remaining hydrogen in the still, emits reaction solution.Filter filtration catalizer removes alcohol solvent under reduced pressure, obtains the 105.5g white solid, yield 96.2%.
Embodiment 3
The preparation of the positive amide-based small methyl benzoate of 3-methyl-4-(4)
In the 3L there-necked flask that reflux condensing tube, thermometer are housed, add 182g(1.1mol) compound 3, add 1.6L acetonitrile and 350mL triethylamine successively under stirring.Under the ice-water bath condition, drip 160.5g n-butyryl chloride (1.5mol) in the there-necked flask by constant pressure funnel, the temperature in the control dropping process is no more than 20 ℃, this moment the reaction solution liquid that is creamy white.Drip and finish, slowly be warming up to backflow, the solution clear.Stirring reaction 2h naturally cools to room temperature, the white solid that filtering is separated out.Remove acetonitrile solution under reduced pressure, solid residue is used saturated Na respectively
2CO
3Solution and water washing are neutral until washings for several times.Filtration cakes torrefaction, behind the ethyl alcohol recrystallization white solid, the 229g that weighs, yield 88.5%, m.p.118～120 ℃.
Embodiment 4
The preparation of 4-methyl-2-n-propyl-1H-benzoglyoxaline-6-formic acid (7)
In having the 3L there-necked flask of thermometer, mechanical stirrer, add the positive amide-based small methyl benzoate of 300g3-methyl-4-4(1.275mol), place the cold cycle pump, setting medium temperature is-15 ℃, slowly drip the 900mL nitrosonitric acid with constant pressure funnel, the control rate of addition maintains between-15～-10 ℃ reacting liquid temperature.Dropwise the back in stirring reaction 3h, stopped reaction.Reaction solution is poured in the frozen water, separates out a large amount of yellow solids, suction filtration, and the filter cake washing obtains yellow solid 312.8g after the drying.
In 2L hydrogenation still, add the 1.2mL dehydrated alcohol, 6.25g Raney Ni catalyzer and 125g gained yellow solid pump air with oil pump, logical N
2Gas is drained air in the still for three times, leads to H in still
2Gas is to 2.2MPa.Adjust the reactor controller, be warming up to 80 ℃ after observing response still internal pressure, when hydrogen pressure no longer reduces, react 2h with this understanding.Reactant is cooled to room temperature, discharges remaining hydrogen in the still, emits reaction solution.Filter filtration catalizer removes alcohol solvent under reduced pressure, obtains faint yellow solid 100.5g.
In the 3L there-necked flask of thermometer, magnetic stirrer, reflux condensing tube and alkaline drying tube is housed, add the above-mentioned gained faint yellow solid of 200g (compound 6 crude products) and 1.2L Glacial acetic acid, after being heated to back flow reaction 1h, remove solvent acetic acid under reduced pressure, get the sticky thing of reddish-brown, extract with ethyl acetate (500mL * 3), the ester layer washes with water for several times to neutral, water layer extracts with ethyl acetate (100mL * 3), merge organic phase, after removing ethyl acetate under reduced pressure, add 800mL methyl alcohol and 400mL6molL
-1The NaOH aqueous solution, heating, the reaction solution color is by the orange burgundy that gradually becomes, and refluxes and is down to room temperature behind the reaction 3h down.Steam except the methyl alcohol in the reaction solution, the dilute hydrochloric acid with 5% is regulated residuum pH to 6～7, leaves standstill the several seconds, separates out a large amount of solids.Suction filtration, filter cake wash with water for several times the back dry white solid 114.5g, calculating four step overall yields by raw material 4 is 57%, m.p.180～182 ℃.
Embodiment 5
(the preparation of 1-methyl isophthalic acid H-benzimidazolyl-2 radicals-yl)-1H-benzoglyoxaline (9) of 4-methyl-2-n-propyl-6-
Thermometer is being housed; add 114g (467.4mmol) N-methyl-o-phenylenediamine hydrochloride and 129g (467.4mmol) compound 7 in the 3L there-necked flask of mechanical stirrer and reflux condensing tube; add 1; 2-propylene glycol 1.8L; under nitrogen protection, begin heating; react 20h under the reflux conditions; this moment, reaction solution was blackish green; having reacted afterreaction liquid pours in the 2L frozen water; regulate pH to 9～10 with concentrated ammonia solution; separate out a large amount of green solid, filter, solid dissolves with the mixing solutions of 500mL ethyl acetate-methyl alcohol (30:5); the filtering insolubles; add activated carbon and boil the 30min decolouring, remove mixed solvent under reduced pressure, obtain white solid 134.5g; productive rate 71.5%, m.p.133～135 ℃.
Embodiment 6
4'-{[4-methyl-6-(1-methyl isophthalic acid H-benzimidazolyl-2 radicals-yl)-2-n-propyl-1H-benzoglyoxaline-1-yl] methyl } preparation of biphenyl-2-methyl-formiate (11)
In the 3L there-necked flask of thermometer is housed, add 134.5g(442.5mmol) compound 9 and 1200mL N, dinethylformamide, place ice-water bath, add 59.2g potassium tert.-butoxide (527.2mmol) under the induction stirring, after the control temperature is-5～0 ℃ of stirring reaction 1h, add 161.0g compound 4'-bromomethylbiphenyl-2-methyl-formiate 10(527mmol in batches), rise to room temperature (about 30 ℃) naturally, about 8h afterreaction finishes.Pour in the 1000mL frozen water, fully stir the back with dichloromethane extraction (300mL * 3), merge organic phase, wash organic phase with water for several times, anhydrous MgSO
4Dry 4h, methylene dichloride is removed in decompression, gets white solid 191.5g, productive rate 82%, m.p.181～183 ℃.
Embodiment 7
The preparation of telmisartan (12)
In the 3L there-necked flask of reflux condensing tube is housed, add 190g(359.5mmol successively) compound 11, the NaOH aqueous solution of 1500mL methyl alcohol and 500mL10% fully mixes under the induction stirring, temperature rising reflux reaction 3h, reaction solution is cooled to room temperature, filter the filtering solid, remove solvent methanol under reduced pressure, the dilute hydrochloric acid with 10% is regulated pH and is about 5, separate out a large amount of faint yellow precipitations, filter the back dry cake, obtain the thick product 167.2g of telmisartan, productive rate 90.5%.
In having the 3000mL single port bottle of reflux condensing tube, add 167.2g telmisartan crude product, 5g gac and 835mL dimethyl formamide (DMF) respectively, be heated to 100 ℃ under the induction stirring.Filtered while hot filtering gac after stirring 30min under this temperature, filtrate naturally cools to the room temperature after-filtration, filter cake is used a small amount of dimethyl formamide (DMF) and water wash successively, the dry telmisartan highly finished product 151.3g that gets, the recrystallization yield is 90.5%, m.p.270～271 ℃, HPLC purity 〉=99.2.
Claims (5)
1. process modification for preparing telmisartan, it is characterized in that: when the positive amide-based small methyl benzoate of intermediate 3-methyl-4-prepares intermediate 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid through nitrated, reduction, cyclization, hydrolysis four-step reaction, crude product to nitrated, reduction and ring-closure reaction is not purified, and is 6～7 to reach the purification purpose by the pH that regulates hydrolysis reaction gained reaction solution.
2. by the described method for preparing 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid of claim 1, it comprises following step:
(a) be that raw material carries out nitration reaction with the positive amide-based small methyl benzoate of 3-methyl-4-.Add elutriation after reaction finishes and go out solid, filter and wash with water filter cake, the dry nitration product that gets.
(b) nitration product of step (a) gained carries out hydrogenation reduction.Reaction finishes the after-filtration filtration catalizer, removes solvent under reduced pressure and gets reduzate.
(c) reduzate cyclization in Glacial acetic acid of step (b) gained.Reaction removes the cyclization product that Glacial acetic acid gets thickness under reduced pressure after finishing.
(d) the thick product of step (c) gained steams except ethyl acetate after with ethyl acetate extraction, in the mixed solvent of methanol-water, adds the mineral alkali reaction that is hydrolyzed.Reaction removes methyl alcohol under reduced pressure after finishing, and pH is 6～7 with dilute hydrochloric acid conditioned reaction liquid, leaves standstill and separates out solid, filtration, washing, the dry 2-n-propyl-4-methyl-benzoglyoxaline-6-carboxylic acid that gets.
3. by claim 1 and 2 described methods, wherein the used nitrating agent of nitration reaction is nitrosonitric acid, the volume of nitrosonitric acid is 3～5 times of the positive amide-based small methyl benzoate of 3-methyl-4-quality, and temperature of reaction is-15～-12 ℃, and the reaction times is 3～5 hours.
4. by claim 1 and 2 described methods, wherein the ring-closure reaction condition is: the volumetric usage of Glacial acetic acid is 5～10 times of reduzate quality, and the reaction times is 50～80min, and temperature of reaction is 120～150 ℃.
5. by claim 1 and 2 described methods, wherein the used raw materials quality ratio of the used mixed solvent volume of hydrolysis reaction and ring-closure reaction is: 5:1～8:1, mixed solvent consist of methyl alcohol: 6molL
-1The NaOH aqueous solution=1.8:1～2.2:1,80～120 ℃ of temperature of reaction, 3 hours reaction times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310270872 CN103319414A (en) | 2013-07-01 | 2013-07-01 | Improved telmisartan preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310270872 CN103319414A (en) | 2013-07-01 | 2013-07-01 | Improved telmisartan preparation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103319414A true CN103319414A (en) | 2013-09-25 |
Family
ID=49188506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310270872 Pending CN103319414A (en) | 2013-07-01 | 2013-07-01 | Improved telmisartan preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103319414A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104610161A (en) * | 2015-01-05 | 2015-05-13 | 河南师范大学 | Preparation method for telmisartan |
| JP2015160810A (en) * | 2014-02-26 | 2015-09-07 | 株式会社トクヤマ | METHOD OF PRODUCING 4-METHYL-6(1-METHYLBENZIMIDAZOL-2-YL)-2-n-PROPYL-1H-BENZIMIDAZOLE |
| CN106008356A (en) * | 2016-06-07 | 2016-10-12 | 浙江华海药业股份有限公司 | Preparation method for telmisartan |
| CN107118161A (en) * | 2017-05-05 | 2017-09-01 | 湖北工业大学 | The synthetic method of the carboxylic acid of 2 n-propyl, 4 tolimidazole 6 |
| CN110836943A (en) * | 2019-11-29 | 2020-02-25 | 江西杏林白马药业有限公司 | Analysis method for impurity detection of telmisartan tablets and telmisartan capsules |
| CN111423382A (en) * | 2020-04-03 | 2020-07-17 | 南京国星生物技术研究院有限公司 | Preparation method of telmisartan key intermediate |
| CN111925299A (en) * | 2020-08-13 | 2020-11-13 | 浙江金立源药业有限公司 | Continuous flow method for synthesizing 3-methyl-4-butyryl-5-nitrobenzoic acid methyl ester and reaction device thereof |
-
2013
- 2013-07-01 CN CN 201310270872 patent/CN103319414A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015160810A (en) * | 2014-02-26 | 2015-09-07 | 株式会社トクヤマ | METHOD OF PRODUCING 4-METHYL-6(1-METHYLBENZIMIDAZOL-2-YL)-2-n-PROPYL-1H-BENZIMIDAZOLE |
| CN104610161A (en) * | 2015-01-05 | 2015-05-13 | 河南师范大学 | Preparation method for telmisartan |
| CN106008356A (en) * | 2016-06-07 | 2016-10-12 | 浙江华海药业股份有限公司 | Preparation method for telmisartan |
| CN107118161A (en) * | 2017-05-05 | 2017-09-01 | 湖北工业大学 | The synthetic method of the carboxylic acid of 2 n-propyl, 4 tolimidazole 6 |
| CN107118161B (en) * | 2017-05-05 | 2019-12-31 | 湖北工业大学 | Synthesis method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid |
| CN110836943A (en) * | 2019-11-29 | 2020-02-25 | 江西杏林白马药业有限公司 | Analysis method for impurity detection of telmisartan tablets and telmisartan capsules |
| CN111423382A (en) * | 2020-04-03 | 2020-07-17 | 南京国星生物技术研究院有限公司 | Preparation method of telmisartan key intermediate |
| CN111423382B (en) * | 2020-04-03 | 2022-03-15 | 南京国星生物技术研究院有限公司 | Preparation method of telmisartan key intermediate |
| CN111925299A (en) * | 2020-08-13 | 2020-11-13 | 浙江金立源药业有限公司 | Continuous flow method for synthesizing 3-methyl-4-butyryl-5-nitrobenzoic acid methyl ester and reaction device thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103319414A (en) | Improved telmisartan preparation process | |
| CN102557977A (en) | Synthesis intermediate of erlotinib and preparation method thereof | |
| CN103570633B (en) | The preparation method of Gefitinib | |
| CN102367260A (en) | Synthesis method of 2-aminopyrimidine-5-boric acid | |
| CN102134212B (en) | Preparation method of Oxiracetam | |
| CN104447597B (en) | A kind of preparation method of diclazuril | |
| CN103483324A (en) | New preparation method of lapatinib | |
| CN102351778A (en) | Preparation method of arbidol hydrochloride | |
| CN102924436A (en) | Refining method of fasudil hydrochloride | |
| CN104804008B (en) | A kind of method of suitability for industrialized production methylsulfonic acid Telatinib | |
| CN107098822A (en) | A kind of preparation method for preparing the hydroxy acetophenone of 3 amino of Pranlukast key intermediate 2 | |
| CN103965020B (en) | Prepare the method for 5-iodo-2-bromobenzyl alcohol | |
| CN112479993A (en) | Synthetic method applied to KRAS inhibitor drug heterocyclic intermediate | |
| CN102976958A (en) | Preparation method of 4-methoxy-beta-phenylethylamine | |
| CN105175316B (en) | A kind of method for preparing laxative picosulfate sodium | |
| CN105175317B (en) | A kind of method for preparing picosulfate sodium | |
| CN105669539B (en) | A kind of preparation process of 2- amino -3- fluorine pyridines | |
| CN103664645B (en) | The industrialized process for preparing of 1,8-diaminonaphthalene | |
| CN104130154A (en) | Method for preparing high-purity agomelatine | |
| CN108164423A (en) | A kind of preparation method of naftifine hydrochloride | |
| CN103910695B (en) | A kind of synthetic method of Febuxostat | |
| CN106883166A (en) | 4-（3- piperidyls）The preparation method of aniline and its tartrate | |
| CN101696185B (en) | Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid | |
| CN102086147A (en) | Preparation method of substituted phenol | |
| CN106117190B (en) | A kind of synthetic method of times of good fortune Pulan |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130925 |